TABLE OF CONTENTS
1 INTRODUCTION 21
1.1 OBJECTIVES OF THE STUDY 21
1.2 MARKET DEFINITION 21
1.3 OVERVIEW OF THE NORTH AMERICA MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET 21
1.4 CURRENCY AND PRICING 24
1.5 LIMITATION 24
1.6 MARKETS COVERED 24
2 MARKET SEGMENTATION 30
2.1 MARKETS COVERED 30
2.2 GEOGRAPHIC SCOPE 31
2.3 YEARS CONSIDERED FOR THE STUDY 32
2.4 CURRENCY AND PRICING 32
2.5 RESEARCH METHODOLOGY 33
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 36
2.7 MULTIVARIATE MODELLING 37
2.8 TYPE SEGMENT LIFELINE CURVE 37
2.9 DBMR MARKET POSITION GRID 38
2.10 VENDOR SHARE ANALYSIS 40
2.11 MARKET APPLICATION COVERAGE GRID 41
2.12 THE CATEGORY VS TIME GRID 42
2.13 SECONDARY SOURCES 43
2.14 ASSUMPTIONS 43
3 EXECUTIVE SUMMARY 44
4 PREMIUM INSIGHTS 47
4.1 PESTEL ANALYSIS 48
4.2 PORTER'S FIVE FORCE 49
4.3 KEY STRATEGIC INITIATIVES 50
4.4 EMERGING TREND ANALYSIS OF DIGITAL REHABILITATION AND DIGITAL PHYSIOTHERAPY IN THE NORTH AMERICA MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET 52
4.4.1 DIGITAL REHABILITATION 52
4.4.2 DIGITAL PHYSIOTHERAPY 52
5 EPIDEMIOLOGY 54
5.1 U.S. 54
5.2 CANADA 55
5.3 MEXICO 56
6 NORTH AMERICA MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET: REGULATIONS 68
7 MARKET OVERVIEW 72
7.1 DRIVERS 74
7.1.1 TECHNOLOGICAL ADVANCES IN THE DIAGNOSIS OF MUSCULOSKELETAL DISORDERS (MSDS) 74
7.1.2 RISING AWARENESS ABOUT MUSCULOSKELETAL DISORDERS (MSDS) 74
7.1.3 GROWING PREVALENCE OF RHEUMATOID ARTHRITIS (RA) 75
7.1.4 INCREASING CASES OF BONE FRACTURES 75
7.2 RESTRAINTS 76
7.2.1 HIGH COST OF DIAGNOSIS AND TREATMENT OF ORTHOPEDIC DISEASES 76
7.2.2 RISE IN USE OF HEAVY-DUTY DRUGS IN TREATING MUSCULOSKELETAL (MSK) PAIN 77
7.3 OPPORTUNITIES 77
7.3.1 STRATEGIC INITIATIVES BY MARKET PLAYERS 77
7.3.2 USE OF TELEMEDICINE IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT 78
7.3.3 INCREASED USE OF MUSCULOSKELETAL-FOCUSED DIGITAL APPS (MDAS) FOR MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT 79
7.3.4 USE OF HOME HEALTHCARE FOR MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT 79
7.4 CHALLENGES 80
7.4.1 CHALLENGES FACED BY PHYSICIANS WHILE TREATING ATHLETES WITH MUSCULOSKELETAL (MSK) DISEASES 80
7.4.2 STRICT REGULATORY GUIDELINES FOR MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT 80
8 NORTH AMERICA MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE 81
8.1 OVERVIEW 82
8.2 DIGITAL BIOFEEDBACK SYSTEM 86
8.3 MUSCULOSKELETAL-FOCUSED DIGITAL APPS (MDAS) 87
8.3.1 IOS-SYSTEMS 88
8.3.2 ANDROID-SYSTEMS 88
8.3.3 OTHER SYSTEMS 88
8.4 SOLUTIONS 88
8.4.1 DIRECT SUPPORT 89
8.4.1.1 MULTIMODAL PAIN THERAPY 90
8.4.1.2 ONSITE PERSONALIZED THERAPY 90
8.4.1.3 SOLUTIONS TO REDUCE INJURIES 90
8.4.1.4 MIND-BODY CONNECTION IMPROVEMENT 90
8.4.1.5 EARLY PREVENTION AND INTERVENTION 90
8.4.1.6 PREVENTION, RECOVERY AND EDUCATION 90
8.4.1.7 PERSONALIZED PAIN RECOVERY 90
8.4.1.8 SENSOR-GUIDED EXERCISE THERAPY 90
8.4.1.9 TRAINING OF EDUCATION SKILLS 90
8.4.1.10 SELF-TRACKING OF PAIN EPISODES 90
8.4.1.11 RELAXATION TECHNIQUES 91
8.4.1.12 POST-OPERATIVE PAIN TRACKING 91
8.4.1.12.1 REAL-TIME MONITORING 91
8.4.1.12.2 SYMPTOM MANAGEMENT 91
8.4.1.13 OTHERS 91
8.4.2 PROGRESS TRACKING 91
8.4.3 OTHERS 91
8.5 OTHERS 92
9 NORTH AMERICA MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TECHNOLOGY 93
9.1 OVERVIEW 94
9.2 PRECISION MOTION TECHNOLOGY 98
9.3 COMPUTER MOTION TECHNOLOGY 98
9.4 OTHER TECHNOLOGIES 98
10 NORTH AMERICA MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE 99
10.1 OVERVIEW 100
10.2 PHONE 104
10.2.1 DIGITAL BIOFEEDBACK SYSTEM 105
10.2.2 MUSCULOSKELETAL-FOCUSED DIGITAL APPS (MDAS) 105
10.2.3 THERAPIES 105
10.2.4 OTHERS 105
10.3 TABLET 105
10.3.1 DIGITAL BIOFEEDBACK SYSTEM 107
10.3.2 MUSCULOSKELETAL-FOCUSED DIGITAL APPS (MDAS) 107
10.3.3 THERAPIES 107
10.3.4 OTHERS 107
10.4 COMPUTER 107
10.4.1 DIGITAL BIOFEEDBACK SYSTEM 108
10.4.2 MUSCULOSKELETAL-FOCUSED DIGITAL APPS (MDAS) 108
10.4.3 THERAPIES 108
10.4.4 OTHERS 108
10.5 OTHERS 109
11 NORTH AMERICA MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY MODALITY 110
11.1 OVERVIEW 111
11.2 VIRTUAL THERAPY 115
11.2.1 INTERNET BASED 116
11.2.2 TELEPHONE BASED 116
11.2.3 MOBILE PHONE APPLICATION 116
11.2.4 INTERNET BASED WITH TELEPHONE SUPPORT 116
11.2.5 INTERACTIVE VOICE RESPONSE 117
11.2.6 VIDEO TELECONFERENCING 117
11.2.7 MOBILE PHONE APPLICATION WITH TELEPHONE SUPPORT 117
11.2.8 INTERACTIVE VOICE RESPONSE WITH TELEPHONE SUPPORT 117
11.2.9 INTERNET BASED WITH VIDEO CONFERENCING 117
11.2.10 INTERACTIVE VOICE RESPONSE WITH TELEPHONE SUPPORT AND INTERNET BASED 117
11.2.11 OTHERS 117
11.3 IN-PERSON THERAPY 117
11.4 CUSTOMIZED/ PERSONALIZED THERAPY 118
11.5 OTHERS 119
12 NORTH AMERICA MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION 120
12.1 OVERVIEW 121
12.2 PRE-SURGERY APPLICATION 125
12.2.1 ANTERIOR CERVICAL DISCECTOMY AND FUSION SURGERY 126
12.2.2 ANTERIOR LUMBAR INTERBODY FUSION SURGERY 126
12.2.3 LATERAL LUMBAR INTERBODY FUSION SURGERY 126
12.2.4 INTERNET BASED WITH TELEPHONE SUPPORT 126
12.2.5 MINIMALLY INVASIVE SPINE SURGERY 126
12.2.6 MOTION PRESERVING SPINE SURGERY 126
12.2.7 POSTERIOR CERVICAL FUSION SURGERY 126
12.2.8 POSTERIOR LUMBAR INTERBODY FUSION SURGERY 126
12.2.9 SACROILIAC JOINT FUSION SURGERY 126
12.2.10 SCOLIOSIS CORRECTION SURGERY 127
12.2.11 VERTEBRAL AUGMENTATION SURGERY 127
12.2.12 FRACTURE FIXATION SURGERY 127
12.2.13 HIP SURGERY 127
12.2.13.1 TOTAL HIP REPLACEMENT 127
12.2.13.2 PARTIAL HIP REPLACEMENT 127
12.2.13.3 HIP RESURFACING 127
12.2.13.4 OTHERS 128
12.2.14 KNEE SURGERY 128
12.2.14.1 TOTAL KNEE REPLACEMENT 128
12.2.14.2 PARTIAL KNEE REPLACEMENT 128
12.2.14.3 MISS FUSION 128
12.2.14.4 OTHERS 128
12.3 POST-SURGERY APPLICATION 129
12.3.1 ANTERIOR CERVICAL DISCECTOMY AND FUSION SURGERY 130
12.3.2 ANTERIOR LUMBAR INTERBODY FUSION SURGERY 130
12.3.3 LATERAL LUMBAR INTERBODY FUSION SURGERY 130
12.3.4 INTERNET BASED WITH TELEPHONE SUPPORT 130
12.3.5 MINIMALLY INVASIVE SPINE SURGERY 130
12.3.6 MOTION PRESERVING SPINE SURGERY 130
12.3.7 POSTERIOR CERVICAL FUSION SURGERY 130
12.3.8 POSTERIOR LUMBAR INTERBODY FUSION SURGERY 130
12.3.9 SACROILIAC JOINT FUSION SURGERY 130
12.3.10 SCOLIOSIS CORRECTION SURGERY 130
12.3.11 VERTEBRAL AUGMENTATION SURGERY 131
12.3.12 FRACTURE FIXATION SURGERY 131
12.3.13 HIP SURGERY 131
12.3.13.1 TOTAL HIP REPLACEMENT 131
12.3.13.2 PARTIAL HIP REPLACEMENT 131
12.3.13.3 HIP RESURFACING 131
12.3.13.4 OTHERS 132
12.3.14 KNEE SURGERY 132
12.3.14.1 TOTAL KNEE REPLACEMENT 132
12.3.14.2 PARTIAL KNEE REPLACEMENT 132
12.3.14.3 MISS FUSION 132
12.3.14.4 OTHERS 132
13 NORTH AMERICA MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION 133
13.1 OVERVIEW 134
13.2 PEDIATRICS 138
13.2.1 MALE 138
13.2.2 FEMALE 138
13.3 ADULTS 138
13.3.1 MALE 139
13.3.2 FEMALE 139
13.4 GERIATRIC 139
13.4.1 MALE 140
13.4.2 FEMALE 140
14 NORTH AMERICA MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY END USER 141
14.1 OVERVIEW 142
14.2 HOSPITALS & CLINICS 145
14.2.1 MULTIPLE 145
14.2.2 PHYSICAL THERAPIST 145
14.2.3 NURSE 145
14.2.4 HEALTH COACH 146
14.2.5 OTHERS 146
14.3 NURSING HOMES 146
14.3.1 MULTIPLE 147
14.3.2 PHYSICAL THERAPIST 147
14.3.3 NURSE 147
14.3.4 HEALTH COACH 147
14.3.5 OTHERS 147
14.4 HEALTH CENTERS 147
14.4.1 MULTIPLE 148
14.4.2 PHYSICAL THERAPIST 148
14.4.3 NURSE 148
14.4.4 HEALTH COACH 148
14.4.5 OTHERS 148
14.5 REHABILITATION CENTERS 148
14.5.1 MULTIPLE 149
14.5.2 PHYSICAL THERAPIST 149
14.5.3 NURSE 149
14.5.4 HEALTH COACH 149
14.5.5 OTHERS 150
14.6 VIRTUAL/HOME HEALTH CARE SETTINGS 150
14.6.1 MULTIPLE 151
14.6.2 PHYSICAL THERAPIST 151
14.6.3 NURSE 151
14.6.4 HEALTH COACH 151
14.6.5 OTHERS 151
14.7 OTHERS 151
15 NORTH AMERICA MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY REGION 152
15.1 OVERVIEW 153
15.1.1 U.S. 158
15.1.2 CANADA 170
15.1.3 MEXICO 181
16 NORTH AMERICA MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET: COMPANY LANDSCAPE 192
16.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 192
17 SWOT ANALYSIS 193
18 COMPANY PROFILE 194
18.1 HINGE HEALTH, INC 194
18.1.1 COMPANY SNAPSHOT 194
18.1.2 PRODUCT PORTFOLIO 194
18.1.3 RECENT DEVELOPMENTS 194
18.2 SWORD HEALTH, INC 196
18.2.1 COMPANY SNAPSHOT 196
18.2.2 PRODUCT PORTFOLIO 196
18.2.3 RECENT DEVELOPMENT 196
18.3 OMADA HEALTHA INC. 197
18.3.1 COMPANY SNAPSHOT 197
18.3.2 PRODUCT PORTFOLIO 197
18.3.3 RECENT DEVELOPMENT 197
18.4 KAIA HEALTH 198
18.4.1 COMPANY SNAPSHOT 198
18.4.2 PRODUCT PORTFOLIO 198
18.4.3 RECENT DEVELOPMENTS 199
18.5 WELLNESS COACHES USA, LLC. 200
18.5.1 COMPANY SNAPSHOT 200
18.5.2 PRODUCT PORTFOLIO 200
18.5.3 RECENT DEVELOPMENT 200
18.6 AIRROSTI REHAB CENTER, LLC 202
18.6.1 COMPANY SNAPSHOT 202
18.6.2 PRODUCT PORTFOLIO 202
18.6.3 RECENT DEVELOPMENTS 202
18.7 DARIOHEALTH CORP. (2021) 204
18.7.1 COMPANY SNAPSHOT 204
18.7.2 REVENUE ANALYSIS 204
18.7.3 PRODUCT PORTFOLIO 205
18.7.4 RECENT DEVELOPMENTS 205

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.